UiPath
PATH
$16.39
+2.95%
UiPath, Inc. is a software company that provides an end-to-end enterprise automation platform, initially centered on robotic process automation (RPA) and now expanding into AI-powered automation and agentic AI orchestration. As a pioneer and leader in the RPA market, UiPath differentiates itself through its computer vision technology and broad integration capabilities, serving industries like finance, healthcare, and customer service. The current investor narrative revolves around UiPath's transition from a legacy RPA vendor to an AI-driven automation leader, with recent strong Q1 results and raised guidance fueling optimism that revenue growth is finally translating into sustainable profitability. However, the stock also faces debate over competitive threats from generative AI and its ability to maintain growth in a rapidly evolving market.…
PATH
UiPath
$16.39
Related headlines
Investment Opinion: Should I buy PATH Today?
Rating: Hold. UiPath is a promising growth stock with improving fundamentals, but the current price of $16.01 is above the average analyst target of $13.25, suggesting limited upside. The consensus recommendation is 'hold,' and the stock's recent surge has priced in much of the positive news. Investors should wait for a pullback or more evidence of AI-driven growth before initiating a position.
Sign up to view all
PATH 12-Month Price Forecast
UiPath is at a pivotal point where its AI strategy could either drive significant upside or lead to disappointment. The company's financial turnaround is real, but the valuation already reflects high expectations. I would upgrade my stance to bullish if revenue growth accelerates above 20% and margins expand, or if the stock pulls back to a more attractive entry point. Conversely, I would turn bearish if growth decelerates or if competitive threats materialize, as the current price leaves little room for error.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on UiPath's 12-month outlook, with a consensus price target around $13.44 and implied upside of -18.0% versus the current price.
Average Target
$13.44
0 analysts
Implied Upside
-18.0%
vs. current price
Analyst Count
—
covering this stock
Price Range
$11 - $17
Analyst target range
The target price range spans from a low of $10.98 to a high of $17.00, with the high target suggesting that some analysts see further upside of 6.2% from current levels, likely driven by successful AI integration and sustained revenue growth. The low target implies a potential downside of -31.4%, which could materialize if competitive pressures from generative AI intensify or if the company fails to meet elevated expectations. The wide spread of $6.02 between the low and high targets indicates significant uncertainty about UiPath's future performance, reflecting the ongoing debate over its competitive position in the AI era. Recent institutional ratings have been largely neutral, with no major upgrades or downgrades in the past few months, suggesting that analysts are adopting a wait-and-see approach until more evidence of AI-driven growth emerges.
Bulls vs Bears: PATH Investment Factors
UiPath presents a compelling turnaround story with accelerating revenue growth, GAAP profitability, and a strong balance sheet, but faces significant competitive and valuation risks. The bull case is supported by tangible financial improvements and the strategic positioning in AI-driven automation, while the bear case hinges on the threat from generative AI and the stock's rich valuation relative to analyst targets. Currently, the evidence slightly favors the bulls given the recent momentum and raised guidance, but the wide analyst target range ($10.98-$17.00) underscores high uncertainty. The most critical tension is whether UiPath can successfully transition from RPA to AI orchestration without losing market share to larger tech players, which will determine if the current growth and profitability are sustainable.
Bullish
- Revenue growth accelerating to 17.3% YoY: Q1 FY2027 revenue of $418.4M grew 17.3% YoY, up from 13.5% in Q1 FY2026 and 14.2% in Q2 FY2026, showing clear acceleration. This momentum is driven by subscription revenue of $252.9M and license revenue of $149.3M, indicating strong demand for the platform.
- Achieved GAAP profitability with positive net income: Q1 FY2027 net income was $22.5M, a sharp turnaround from a -$22.6M loss in the year-ago quarter. This marks the second consecutive profitable quarter, with EPS of $0.04, demonstrating that the business model is scaling efficiently.
- Raised guidance signals confidence in AI-driven growth: Following strong Q1 results, management raised full-year guidance, reflecting optimism about the AI-driven automation opportunity. The stock surged 33.97% in the past month, indicating investor confidence in the company's ability to capitalize on the agentic AI trend.
- Strong balance sheet with minimal debt: Debt-to-equity is only 0.039, and the current ratio is 2.48, indicating ample liquidity. This financial flexibility allows UiPath to invest in AI innovation and navigate competitive pressures without balance sheet strain.
Bearish
- Analyst consensus is Hold with limited upside: The average analyst target price is $13.25, implying a -17.2% downside from the current price of $16.01. With a recommendation of 'hold' and a mean score of 2.8, analysts see limited near-term upside, reflecting uncertainty about the AI transition.
- Valuation premium to peers may compress: The trailing PE of 24.2x and forward PE of 17.7x are elevated relative to the software sector median. If growth decelerates or AI competition intensifies, the multiple could contract, leading to significant downside.
- Competitive threat from generative AI: Generative AI tools like Microsoft's Copilot and other automation platforms could disrupt UiPath's core RPA market. The Motley Fool article from Feb 18, 2026, highlighted 'existential competition from generative AI that could permanently impair its growth trajectory.'
- High volatility and recent price surge may be overextended: The stock is up 55.9% in the last 3 months and 33.97% in the last month, trading near the 52-week high of $19.84. This rapid appreciation may have priced in near-term optimism, leaving little room for error in upcoming earnings.
PATH Technical Analysis
UiPath's stock has exhibited a robust recovery over the past year, with a 1-year price change of +49.2%, significantly outperforming the S&P 500's +20.4% over the same period. The current price of $16.01 sits at 81% of its 52-week range (low of $9.20, high of $19.84), indicating a strong upward trend that has reclaimed much of the ground lost from earlier declines. This positioning near the upper end of the range suggests momentum and investor confidence, though it also raises the risk of overextension in the near term.
Beta
0.96
0.96x market volatility
Max Drawdown
-51.4%
Largest decline past year
52-Week Range
$9-$20
Price range past year
Annual Return
+50.5%
Cumulative gain past year
| Period | PATH Return | S&P 500 |
|---|---|---|
| 1m | +53.2% | +2.5% |
| 3m | +50.0% | +2.7% |
| 6m | +51.8% | +11.1% |
| 1y | +50.5% | +20.5% |
| ytd | +3.2% | +12.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
PATH Fundamental Analysis
UiPath's revenue trajectory has been accelerating, with the most recent quarter (Q1 FY2027, ended April 30, 2026) reporting revenue of $418.4 million, a 17.3% year-over-year increase. This growth rate is a notable improvement from the prior year's quarters, where revenue grew from $356.6 million in Q1 FY2026 to $361.7 million in Q2 FY2026, then to $411.1 million in Q3 FY2026, and $481.1 million in Q4 FY2026, indicating a clear acceleration trend. The growth is driven by subscription services revenue of $252.9 million and license revenue of $149.3 million, with professional services contributing $31.3 million, showing a healthy mix of recurring and one-time revenue streams.
Quarterly Revenue
$418382000.0B
2026-04
Revenue YoY Growth
+17.3%
YoY Comparison
Gross Margin
81.1%
Latest Quarter
Free Cash Flow
$375234000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is PATH Overvalued?
Given UiPath's positive net income of $22.5 million in the most recent quarter, the PE ratio is the most appropriate valuation metric. The trailing PE stands at 24.2x, while the forward PE is 17.7x, implying that the market expects earnings growth of approximately 37% over the next year. This forward discount suggests that investors are pricing in continued profitability improvements, which is supported by the company's recent margin expansion and raised guidance.
PE
24.2x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 11x~96x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
50.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financial risks include the company's reliance on continued revenue growth to justify its valuation. While UiPath achieved positive net income of $22.5M in Q1 FY2027, its operating margin is only 7.3%, leaving limited cushion for downturns. The company's free cash flow of $375M TTM is positive, but the high EV/EBITDA of 50.9x suggests that any earnings miss could trigger a sharp de-rating. Additionally, revenue concentration in the Americas (largest region) exposes it to regional economic fluctuations, and the recent surge in stock price (up 55.9% in 3 months) has increased vulnerability to profit-taking.